To include your compound in the COVID-19 Resource Center, submit it here.

JNJ reports Remicade psoriasis data

In a double-blind, placebo-controlled Phase II study of 33 psoriasis patients, 5

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE